How many institutions held GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q2 2025?

46 institutional investors reported GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q2 2025. Use the holders table for investor-level position and value details.

GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (GYRE)

Q: What does CUSIP 403783103 represent in this 13F holders report?

CUSIP 403783103 is the security identifier for GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 403783103

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 3,409,744
Total 13F value: $25,061,360
Share change: +798,188
SEC-reported price per share: $7.35
Number of holders: 46
Value change: +$5,853,520
Number of buys: 32
Number of sells: 14
Shares outstanding: 124,924,768

Security key

403783103

Report period

Q2 2025

Institutions

Top holders

GYRE full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 GYRE THERAPEUTICS, INC. SEC filings GYRE THERAPEUTICS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 403783103

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q2 2026 Q3 2025

Ownership snapshot

Top reported holders of GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Songjiang Ma

Disclosed value leader

Songjiang Ma

Comparable rows

0/15

Latest evidence

27 May 2025

3/4/5 13F Highest disclosed value: $28,257,265 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Songjiang Ma has the largest disclosed position value at $28.26M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Songjiang Ma's linked filing trail.

Disclosed position value Top 5

Songjiang Ma $28.26M

VANGUARD GROUP INC $8.46M

BlackRock, Inc. $4.22M

GEODE CAPITAL MANAGEMENT, LLC $2.41M

STATE STREET CORP $994.1K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Songjiang Ma	3/4/5 President, Director 3/4/5	— mixed-class rows	$28,257,265 2,832,084 shares mixed-class rows	—	27 May 2025
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$8,464,887 1,096,488 shares	—	31 Mar 2025
BlackRock, Inc.	13F Company 13F	— denominator unverified	$4,224,460 547,210 shares	—	31 Mar 2025
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$2,411,773 312,319 shares	—	31 Mar 2025
STATE STREET CORP	13F Company 13F	— denominator unverified	$994,128 128,773 shares	—	31 Mar 2025
SBI Securities Co., Ltd.	13F Company 13F	— denominator unverified	$954,416 123,629 shares	—	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,409,744

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q2 2026 Across Filers

Q2 2026 holders

Q2 2025 holders

Holder diff

-12

Investor	Q2 2026 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q2 2026 value	Q2 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend